SCHEMBL14059204

SCHEMBL14059204

N#Cc1nnc2cc(-c3ccncc3)ccc2c1NCCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 10/20 0.46
▸ CDK8 P49336 3/20 0.46
▸ ROCK1 Q13464 2/20 0.46
▸ GSK3B P49841 2/20 0.46
▸ PRKACA P17612 1/20 0.46
▸ CLK2 P49760 1/20 0.46
▸ GSK3A P49840 1/20 0.46
▸ CDK9 P50750 1/20 0.46
▸ CDK5 Q00535 1/20 0.46
▸ PRKCQ Q04759 1/20 0.46
▸ DYRK1A Q13627 1/20 0.46
▸ CLK4 Q9HAZ1 1/20 0.46
▸ DYRK1B Q9Y463 1/20 0.46
▸ KDM4E B2RXH2 4/20 0.43
▸ MAPK1 P28482 3/20 0.43
▸ NRP1 O14786 1/20 0.42
▸ CCNC P24863 2/20 0.41
▸ HTT P42858 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ ROCK2 O75116 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14059310 0.91 LRRK2 (0.44) LRRK2CDK8ROCK1GSK3BPRKACA
SCHEMBL14059030 0.85 LRRK2 (0.64) LRRK2
SCHEMBL14059209 0.84 LRRK2 (0.64) LRRK2CDK8ROCK1GSK3BPRKACA
SCHEMBL14060221 0.82 LRRK2 (0.65) LRRK2CDK8ROCK1GSK3BPRKACA
SCHEMBL14059726 0.79 LRRK2 (0.75) LRRK2GSK3BCLK4ROCK2
SCHEMBL14059810 0.76 LRRK2 (0.65) LRRK2
SCHEMBL14059811 0.76 LRRK2 (0.65) LRRK2
SCHEMBL17135925 0.76 LRRK2 (0.65) LRRK2
SCHEMBL14059965 0.75 LRRK2 (0.71) LRRK2
SCHEMBL14059734 0.74 LRRK2 (0.63) LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2726465-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY Elan Pharmaceuticals Inc. (US) 2014-05-07 — — EP claimed
WO-2012162254-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY ELAN PHARMACEUTICALS, INC. (US) 2012-11-29 — — WO claimed
EP-2726465-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY Elan Pharmaceuticals Inc. (US) 2014-05-07 — — EP disclosed
WO-2012162254-A1 INHIBITORS OF LRRK2 KINASE ACTIVITY ELAN PHARMACEUTICALS, INC. (US) 2012-11-29 — — WO disclosed
Send feedback